$GILD GILEAD SCIENCES INC Insider Trading Week 10/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC in week 10/2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 0.00 | 15,845 | 0 | 47,435 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 63.91 | 92,205 | 5,892,822 | 92,205 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,025 | 0 | 31,590 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Payment of Exercise | F | 63.91 | 1,435 | 91,711 | 27,564 | 29 K to 27.6 K (-4.95 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Buy | M | 0.00 | 3,025 | 0 | 28,999 | 26 K to 29 K (+11.65 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,794 | 0 | 42,936 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Option Exercise | A | 0.00 | 16,430 | 0 | 46,730 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Option Exercise | A | 63.91 | 95,620 | 6,111,074 | 95,620 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Payment of Exercise | F | 63.91 | 1,771 | 113,185 | 34,930 | 36.7 K to 34.9 K (-4.83 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Buy | M | 0.00 | 3,794 | 0 | 36,701 | 32.9 K to 36.7 K (+11.53 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | Chief Financial Off ... | Grant | A | 56.86 | 364 | 20,696 | 32,907 | 32.5 K to 32.9 K (+1.12 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 0.00 | 5,085 | 0 | 18,387 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 63.91 | 17,110 | 1,093,500 | 17,110 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 2,025 | 0 | 13,302 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 63.91 | 609 | 38,921 | 18,825 | 19.4 K to 18.8 K (-3.13 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 2,025 | 0 | 19,434 | 17.4 K to 19.4 K (+11.63 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 63.91 | 96,760 | 6,183,932 | 96,760 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 0.00 | 16,625 | 0 | 37,189 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,455 | 0 | 20,564 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Payment of Exercise | F | 63.91 | 1,639 | 104,748 | 14,079 | 15.7 K to 14.1 K (-10.43 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Buy | M | 0.00 | 3,455 | 0 | 15,718 | 12.3 K to 15.7 K (+28.17 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Grant | A | 56.86 | 364 | 20,696 | 12,263 | 11.9 K to 12.3 K (+3.06 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 63.91 | 72,855 | 4,656,163 | 72,855 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 0.00 | 12,520 | 0 | 25,751 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 0.00 | 2,593 | 0 | 13,231 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 63.36 | 1,486 | 94,153 | 29,166 | 30.7 K to 29.2 K (-4.85 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Payment of Exercise | F | 63.91 | 1,107 | 70,748 | 30,652 | 31.8 K to 30.7 K (-3.49 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 0.00 | 2,593 | 0 | 31,759 | 29.2 K to 31.8 K (+8.89 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 56.86 | 334 | 18,990 | 29,166 | 28.8 K to 29.2 K (+1.16 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 10,800 | 0 | 150,856 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 63.91 | 307,355 | 19,643,058 | 307,355 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 0.00 | 52,810 | 0 | 161,656 | |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Payment of Exercise | F | 63.91 | 5,123 | 327,411 | 142,013 | 147.1 K to 142 K (-3.48 %) |
Mar 12 2021 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 10,800 | 0 | 147,136 | 136.3 K to 147.1 K (+7.92 %) |